Arbital Health
427 Mendocino Avenue, Suite 100, Santa Rosa, CA, 95401, United States
Overview
Arbital Health offers an AI-powered platform and a market-leading actuarial team that centralizes fragmented data, automates contract reconciliation, and delivers actuarially driven insights for value-based care. Its product suite includes an Adjudication Module with an Overall Risk Performance Dashboard, plus Performance Monitor and Insights modules that surface KPIs and drivers of risk. The company aims to expand payer- and provider-facing capabilities and grow its actuarial team to accelerate contract performance monitoring, management, and reconciliation across major risk models. Arbital has built a client roster of more than 40 payers, providers, digital point solutions, value-based care enablers, and integrated delivery networks, and has onboarded over 600,000 patient lives to its platform. The company emphasizes reducing administrative burden and increasing transparency to improve engagement, risk scores, and patient outcomes. Arbital was founded in 2024 and operates its team onsite in San Francisco. Arbital Health provides neutral third-party adjudication for outcomes-based contracts across the value-based care landscape, serving payers, providers, life sciences companies, employers, and digital health firms. The company’s initial product offering includes value assessment for point-solution health vendors, value analysis for payers (including employers and health plans), and actuarial advisory services. Arbital expanded its actuarial and consulting capabilities through the acquisition of Santa Barbara Actuaries, Inc., which specializes in value-based contracting, predictive modeling, and data analytics. The acquisition enables Arbital to offer a dedicated value-based care actuarial team and access to SBA’s clients. Arbital is co-founded by Travis May and Brian Overstreet. The company recently completed a $10M Series A financing to support growth and product rollout.
- Total raised
- $41M
- Funding rounds
- 2
- Latest round
- Series B
- Latest activity
- Jul 2025
Industries
- Health Care
- Medical
- Wellness
Recent funding
Series B
Jul 2025
$31M
Series A
Jan 2024
$10M